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Abstract 
Campylobacter jejuni is a leading cause of foodborne illness globally. In this study, a spray 
drying and packaging process was developed to produce a thermally-stable dry powder 
containing bacteriophages that retains biological activity against C. jejuni after long distance 
shipping at ambient temperature. Spray drying using a twin-fluid atomizer resulted in 20 
significantly less (p < 0.05) titer reduction than spray drying using a vibrating mesh 
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nebulizer. The use of centrifugation and dilution of filtered bacteriophage lysate in the 
formulation step resulted in a significantly greater (p < 0.05) proportion of bacteriophages 
remaining active relative to use of no centrifugation and dilution. The spray-dried 
bacteriophage powder generated using leucine and trehalose as excipients was flowable, 25 
non-cohesive, and exhibited a high manufacturing yield. The powder retained its titer with 
no significant differences (p > 0.05) in biological activity after storage in suitable packaging 
for at least 3 weeks at room temperature and after ambient temperature shipping a total 
distance of approximately 19,800 kilometers, including with a 38°C temperature excursion. 
The bacteriophage powder therefore appears suitable for global distribution without the 30 
need for cold chain infrastructure. 
Keywords: Campylobacter jejuni, global health, particle engineering, phage CP20, phage 
CP30A, shipping stability 
Abbreviations: CFU = colony-forming unit; PFU = plaque-forming unit; phage = 
bacteriophage; SEM = scanning electron micrograph; TEM = transmission electron 35 
micrograph 
1 Introduction 
The gram-negative bacterium Campylobacter jejuni causes foodborne illness globally 
(Kaakoush et al., 2015). C. jejuni is prevalent in the gut of chickens and can be present and 
persist at high concentrations in raw or improperly-cooked meat with an attendant high risk 40 
of cross-contamination (Osano & Arimi, 1999; Kittler et al., 2013; Wagenaar et al., 2013; 
Kaakoush et al., 2015). In Kenya, C. jejuni is one of many foodborne bacteria that poses a 
substantial threat of mortality to children (O’Reilly et al., 2012; World Health Organization, 
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2012; Carron et al., 2018). Unfortunately, antibiotic-resistant C. jejuni strains are becoming 
increasingly prevalent (Moore et al., 2006; Kaakoush et al., 2015).  45 
Bacteriophages (phages) are viruses ubiquitous in the global environment, their presence 
dependent on the availability of suitable bacterial hosts. Phages active against C. jejuni, 
including antibiotic-resistant strains, have been isolated from chickens and may be useful 
for decontamination and biocontrol of C. jejuni (Loc Carrillo et al., 2005; Wagenaar et al., 
2005; Kittler et al., 2013; Janež et al., 2014; Firlieyanti et al., 2016). An advantage of using 50 
phages instead of broad spectrum antibiotics is that one species of phage typically infects 
only a narrow spectrum of bacteria, thus not substantially impacting other beneficial 
community members of the microbiota (Kutter and Sulakvelidze, 2005; Kutter et al., 2010; 
Loc-Carrillo et al., 2011; Richards et al., 2019). Also, phages do not interact directly with 
animal or human cells, thereby minimizing any unwanted side effects. 55 
Spray drying can be used to produce dry powder that has improved thermal stability relative 
to liquid dosage forms, potentially removing the need for cold chain shipping (Carrigy & 
Vehring, 2019). Additionally, dry powder has less weight and volume compared to liquid, 
which can reduce transportation costs and storage space requirements (Walters et al., 
2014). Compared to another commonly used method for powder production, lyophilization, 60 
spray drying is a low-cost process (Quinn, 1965; Roser, 1991; Desai et al., 2005; Holsinger et 
al., 2010; Schwartzbach, 2011; Anandharamakrishnan and Ishwarya, 2015; Siew, 2016; 
Huang et al., 2017). Additionally, lyophilization is a lengthy batch process that is difficult to 
scale-up and typically requires subsequent milling or sieving to adjust the particle size (Hoe 
et al., 2014; Ledet et al., 2015), whereas spray drying is a fast, continuous, and scalable 65 
process for producing powder with controlled particle size, distribution, and density, as well 
as surface composition, roughness, and flowability (Vehring, 2008).  
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Leucine and trehalose are relatively low-cost excipients that have been used successfully for 
spray drying phages. Matinkhoo et al. (2011) dried Burkholderia phages in a leucine and 
trehalose formulation using a Büchi B-90 spray dryer and found ~0.8 log10(PFU/mL) titer 70 
reduction for Myoviridae phage KS4-M and ~0.4 log10(PFU/mL) titer reduction for 
Myoviridae phage KS14. Vandenheuvel et al. (2013) dried Podoviridae phage LUZ19 active 
against Pseudomonas and Myoviridae phage Romulus active against Staphylococcus using a 
ProCepT Micro spray dryer and found ~0.02 log(PFU/mL) titer reduction for phage LUZ19 
and ~2.6log(PFU/mL) for phage Romulus when spray dried using trehalose, which 75 
outperformed the use of either lactose or dextran 35 for stabilizing the phages. It was found 
that on storage these phages were susceptible to inactivation if the trehalose crystallized 
(Vandenheuvel et al., 2014). Leung et al. (2017) observed ~1.3 log10(PFU/mL) titer reduction 
due to formulation and spray drying of Podoviridae phage PEV2 active against Pseudomonas 
using a Büchi B-290 small-scale spray dryer. Formulation with 80% trehalose and 20% 80 
leucine outperformed formulations containing different excipient ratios or mannitol in 
terms of titer reduction after one year of refrigerated storage at 0% or 22% relative 
humidity (Leung et al., 2017). They also showed that spray-dried phage PEV2 and 
Myoviridae phage PEV40 formulated using leucine and trehalose were stable for one year at 
refrigerated or 20°C storage using vacuum packaging (Leung et al., 2018). Chang et al. (2017) 85 
demonstrated that, out of many different excipients (trehalose, lactose, mannitol, glycine, 
leucine, PEG3000, and pluronic F-68) and mass fractions tested with Podoviridae phage 
PEV1, the leading formulation contained 17 mg/mL trehalose and 8 mg/mL leucine, for 
which only 0.2 log10(PFU/mL) titer reduction was observed. However, other formulations 
provided better stabilization to other phages, and this combined with the differences in titer 90 
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reduction in the aforementioned studies, indicates that the manufacturability of phages 
varies such that it needs assessment for each phage. 
The feasibility of spray drying anti-Campylobacter phages has not previously been assessed. 
In this paper, a spray drying process is developed for producing flowable anti-
Campylobacter phage powder using leucine and trehalose excipients that retains biological 95 
activity after room temperature storage and long distance shipping in suitable packaging.  
2 Materials and Methods 
2.1 Phage Stocks 
Phage CP30A (vB_CjeM_CP30A; NCBI nucleotide accession JX569801) is group III phage 
(Fletchervirus) with characteristic genome sizes of approximately 130-135 kb; CP20 100 
(vB_CcoM_CP20; NCBI nucleotide accession MK408758) is a group II phage 
(Firehammervirus) with a characteristic genome sizes of approximately 175-183 kb (Javed et 
al., 2014). Both are Eucampyvirinae of the family Myoviridae that infect a range of C. jejuni 
or C. coli host bacteria. These phages were isolated from chicken excreta and are present in 
chicken gut (Loc Carrillo et al., 2005; Scott et al., 2007a; Scott et al., 2007b; Siringan et al., 105 
2011; Siringan et al., 2014; Javed et al., 2014; Brathwaite et al., 2015; Richards et al., 2019). 
A transmission electron micrograph (TEM) of phage CP30A is given in Figure 1. 
[Insert Figure 1] 
2.2 Phage Amplification 
High titer phage lysates were generated by adding 100 µl of phages at 7 log10(PFU/mL) to 110 
500 µL of bacterial suspension at 8 log10(CFU/mL). This mixture was then transferred to 5 mL 
of melted NZCYM overlay agar, which was pre-tempered to 50°C, and poured onto NZCYM 
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agar plate. After overnight incubation at 42°C under microaerobic conditions, the plates 
were then flooded with water. The host strain was isolated from United Kingdom broiler 
flocks in a previous study (Loc Carrillo et al., 2005). The propagation process is discussed in 115 
detail elsewhere (Cairns et al., 2009). The amplified lysate was passed through a 0.22 µm 
filter. The filtered lysate had a solids content of ~19 mg/mL, as measured post-evaporation 
of suspensions on pre-weighed microscope slides. The filtered lysate was optionally further 
purified 30 mL at a time by centrifugation at 3.4×105 m/s2 [35,000 × g] for 120 minutes at 
4°C. After centrifugation, the supernatant was drained and the pellet was resuspended in 30 120 
mL of reverse osmosis water. The measured solids content of the pellet suspension was 
then less than 0.5 mg/mL. The titer of lysates after filtration or filtration and centrifugation 
was approximately 9.5 log(PFU/mL). 
2.3 Formulation 
The formulation excipients were L-leucine (Code 125121000, lot A0269620; Acrōs Organics, 125 
NJ, USA) and D-(+)-trehalose dihydrate (Cat. no. BP2687; Fisher BioReagents, NH, USA). The 
dissolved excipient concentrations were 7.5 mg/mL leucine and 22.5 mg/mL trehalose for 
most experiments, similar to the leading formulation for spray drying phages in a previous 
study (Chang et al., 2017). Higher dissolved excipient concentrations, 20 mg/mL leucine and 
100 mg/mL trehalose, were also tested and used for shipping experiments. Comparisons 130 
were made between adding the excipients directly to the filtered lysate and diluting the 
filtered and centrifuged lysate 1:100 into pre-prepared excipient solution.  
2.4 Air Drying 
To determine whether desiccation is a major cause of titer reduction, filtered phage lysates 
were air-dried at room temperature for 48 hours in a Petri dish (92 mm diameter; Sarstedt, 135 
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Leicestershire, UK) and assayed. TEM was performed on filtered and centrifuged phage 
CP20 lysate that was air-dried on a TEM mesh stub to examine potential mechanisms of 
inactivation due to desiccation. 
2.5 Atomization 
A titer reduction due to atomization comparison was made between the use of a vibrating 140 
mesh nebulizer (Aerogen Solo; Model no. 06675745, Lot 60201509300103, Ref AG-AS3350-
US; Aerogen Ltd., Dangan, Galway, Ireland) with Pro-X Controller (S/N AP-1510412, Ref AG-
PX-1050-IN; Aerogen Ltd., Dangan, Galway, Ireland) and a custom twin-fluid atomizer. For 
these measurements, 3 mL of filtered lysate with direct addition of leucine and trehalose 
was atomized directly onto a filter (Respirgard II bacterial/viral filter, ref 303EU, lot 145 
12127233; Vital Signs, Inc., Englewood, CO, USA), as per Figure 2. A custom adapter made 
from rigid opaque material simulating plastic (Objet VeroGray RGD850; Stratsys, Ltd., Eden 
Prairie, MN, USA), using a PolyJet 3D printer (Objet Eden 350V High Resolution 3D Printer; 
Stratsys, Ltd., Eden Prairie, MN, USA) connected the filter to the twin-fluid atomizer. No 
adapter was used for the vibrating mesh nebulizer as it fit into the filter. The atomized liquid 150 
remained suspended on the filter fibers and 10 mL of buffer was added and mixed by 
swirling the filter. The mixture was drawn from the filter space using a micropipette and 
assayed.  
[Insert Figure 2] 
The vibrating mesh nebulizer generates droplets of an initial diameter of approximately 5.5 155 
µm [Martin et al., 2011]. For the twin-fluid atomizer, an atomizing gas (nitrogen) flow rate of 
1.5×10-4 kg/s and a liquid spray rate of 1.7×10-5 kg/s were used. The initial mass median 
droplet diameter was approximately 9 µm for these air-liquid ratio settings according to 
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data presented elsewhere (Hoe et al., 2014b). At this atomizing gas flow rate and spray rate 
setting about 13% of the droplet volume evaporates to fully humidify the atomizing gas. As 160 
there was no spray drying gas for these measurements, this results in a relatively small 
amount of droplet desiccation, thus minimizing contact of the phages with the air-liquid 
interface, and ensuring the observed titer reduction is due primarily to shear stress. A 
characteristic shear rate on the order of 1×105 s-1 was expected for the twin-fluid atomizer 
according to a model presented by Ghandi et al. (2012). Phages have remained active after 165 
atomization using a similar shear rate (Leung et al., 2016). 
2.6 Spray Drying 
A comparison of overall titer reduction due to spray drying was made between a modified 
Büchi B-90 spray dryer (Büchi Labortechnik AG; Flawil, Switzerland) that uses the vibrating 
mesh nebulizer and a Büchi B-191 spray dryer (Büchi Labortechnik AG, Flawil, Switzerland) 170 
with upgraded process analytics and controls that uses the custom twin-fluid atomizer. 
Process schematics of the spray dryer installations are given in Figure 3. In the modified 
Büchi B-90 design, the nebulizer was placed outside the spray drying chamber to minimize 
heat exposure of the phages prior to atomization. The collected powder was scraped from 
the collecting electrode onto collection paper and then transferred into a tube for assay. In 175 
the Büchi B-191 design the formulation was fed to the custom twin-fluid atomizer using a 
peristaltic pump (Model no. 7528-30, Masterflex L/S, with pump head model no. 77200-60, 
Easy-load II; Cole-Parmer, Vernon Hills, IL, USA). The powder was captured in a collection 
bottle using a cyclone.  
For both spray dryers an inlet temperature of 70°C was used, which is similar to values that, 180 
in the literature (Matinkhoo et al., 2011; Leung et al., 2016; Leung et al., 2017; Leung et al., 
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2018), worked well for spray drying phages. The surface temperature of the atomized 
droplets is typically assumed to remain near the wet bulb temperature due to evaporative 
cooling (Masters, 1972); therefore, thermal inactivation of the phages is not expected 
during initial stages of solvent evaporation. To demonstrate this, additional measurements 185 
with the Büchi B-191 spray dryer were performed using an inlet temperature of 50°C and 
the level of phage inactivation compared to use of an inlet temperature of 70°C. The drying 
gas flow rate was 100 L/min for the B-90 and 425 L/min for the B-191. The spray rate was 
measured to be 0.1 mL/min for the B-90 and set and measured to be 1 mL/min for the B-
191. Using a process model described elsewhere (Carrigy & Vehring, 2019), for an inlet 190 
temperature of 70°C, the predicted outlet temperature and outlet relative humidity values 
were 44°C and 1.6% for the B-90 and 49°C and 2.9% relative humidity for the B-191. The 
moisture content in the powder, neglecting the small effect of leucine on moisture uptake, 
was thus expected to be ~0.4% for the B-90 and ~0.7% for the B-191 based on trehalose 
moisture uptake data from the literature (Carrigy & Vehring, 2019). Both of these moisture 195 
contents are suitable for long-term physical stability (retention of amorphous structure) of 
trehalose for dry room temperature storage conditions, according to a trehalose-water 
supplemented phase diagram (Carrigy & Vehring, 2019). This is important since the 
trehalose must remain amorphous to ensure glass stabilization; crystallization of trehalose 
has been shown to inactivate phages (Vandenheuvel et al., 2014). Overall titer reduction 200 
(filtered lysate titer, divided by 100 if diluted, minus equivalent powder titer) comparison 
was made between formulations using leucine and trehalose, and ‘Neat’ filtered lysates not 
containing any additional excipients as controls to determine if the excipients were 
improving the titer reduction or not.  
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Scanning electron microscope (SEM) images of spray-dried powder were taken using a field-205 
emission SEM (Zeiss Sigma FESEM, Oberkochen, Germany) at 5000x magnification, using an 
immersion lens (in-lens) detector, a working distance of ~7 mm, and an accelerating voltage 
of 2 kV. A gold coating of ~10 nm was applied prior to imaging with a sputter deposition 
system to minimize charging (Denton II; Denton Vacuum LLC, Moorestown, NJ, USA).  
[Insert Figure 3] 210 
2.7 Powder Packaging and Shipping 
Powder packaging was performed by transferring the collected powder into 5 mL tubes 
(Catalogue no. 0030119487, lot G1710906; Eppendorf AG, Hamburg, Germany) that were 
double heat-sealed in double-bagged aluminium foil bags (Prod no. 139-313; Ted Pella, Inc., 
Redding, CA, USA) with molecular sieve desiccant packs (Cat no. 1523T76; McMaster Carr, 215 
Aurora, OH, USA), as per Figure 4. Heat sealing was performed using an impulse sealer (No. 
912951, type AIE-300; American International Electric, Inc., City of Industry, CA, USA). The 
packaging components were first placed in a nitrogen-purged enclosure set to 25°C and 
approximately 0% relative humidity for 4-10 hours to remove moisture. After spray drying 
with the Büchi B-191, the collection bottle (see Figure 3) was removed, quickly capped, and 220 
placed in the nitrogen-purged enclosure, where the powder was added to the already dried 
out tube. Packaging and heat sealing then took place in the nitrogen-purged enclosure. The 
solid phase of the spray-dried powder stored in the packaging at room temperature for 4 
months was determined using a custom Raman spectrometer developed by Wang et al. 
(2014). 225 
[Insert Figure 4] 
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Packages were shipped between Edmonton, Canada and Nottingham, England (~6,600 km 
one-way) under ambient temperature storage conditions. The shipment contained 
aluminium foil packages surrounded by packing paper and placed in a Styrofoam box within 
a cardboard box. The temperature in the boxes during shipment was recorded with a 230 
temperature monitor (TempTale 4 USB MultiAlarm; Sensitech Canada, Markham, ON, 
Canada). Upon arrival, the dry packages were stored at room temperature in the laboratory 
until just prior to assay, at which time they were opened. 
The timeline and protocol of the shipping study is shown in Figure 5. The same large batch 
of spray-dried phage powder was aliquoted into 4 tubes which were each packaged into 235 
separate aluminium foil packages, termed LT(1), LT(2), LT(3), and LT(4). Package LT(1) was 
shipped and assayed soon after spray drying and is considered the control measurement as 
all spray drying occurred in Canada and all assays in England. Package LT(2) was shipped 
soon after spray drying but was not assayed for 3 weeks. Package LT(3) was shipped to 
England soon after packaging, then shipped back to Canada, then shipped back to England 240 
(~19,800 km total), and then assayed at the same time as LT(2) and LT(4). Package LT(4) was 
kept in Canada and sent in a later shipment to England for assay. Comparison of LT(1) and 
LT(2) titer reduction indicated whether 3 weeks of room temperature storage caused phage 
inactivation. Comparison of LT(3) to the other packages indicated whether multiple 
shipments caused additional titer reduction (e.g. due to shaking during shipping and 245 
handling). Comparison of LT(1) and LT(4) titer reduction indicated whether different 
shipments caused different phage titer reductions.  
[Insert Figure 5] 
2.8 Plaque Assays 
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Plaque assays were performed using C. jejuni as the host strain to determine biological 250 
activity of the phages. Spot assays were performed in triplicate at multiple dilution levels. 
For powder, it was necessary to redissolve into water at a concentration of 30 mg/mL prior 
to performing plaque assay to determine titer. No clear trend in recovered titer was 
observed using buffer or water at different temperatures (4°C, 20°C, 37°C) to redissolve the 
powder. 255 
2.9 Statistics 
Results are generally presented as mean ± standard deviation. Titer results are based on 
spot assays performed in triplicate. The standard deviation in titer reduction was obtained 
by error propagation for subtraction, with the individual standard deviations representing 
the errors. Statistical comparisons utilized the Student’s t-test without assuming equal 260 
variance, at a significance level of 0.05. 
3 Results and Discussion 
3.1 Air Drying 
The titer reductions due to air drying in a Petri dish were 2.0 ± 0.1 log10(PFU/mL) for filtered 
‘Neat’ CP30A lysate, 1.8 ± 0.3 log10(PFU/mL) for filtered CP30A lysate with direct addition of 265 
7.5 mg/mL leucine and 22.5 mg/mL trehalose, 2.0 ± 0.2 log10(PFU/mL) for filtered and 
centrifuged CP30A lysate with direct addition of 7.5 mg/mL leucine and 22.5 mg/mL 
trehalose, and 3.5 ± 0.2 log10(PFU/mL) for filtered and centrifuged CP30A lysate. As the 
filtered and centrifuged lysate without leucine and trehalose had significantly greater titer 
reduction than the other cases (p < 0.001), it was apparent that leucine or trehalose, and 270 
impurities in the lysate, both provide some biological stabilization against desiccation. 
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3.2 Atomization 
The titer reduction upon atomization with the vibrating mesh nebulizer was 0.8 ± 0.2 
log10(PFU/mL) while the titer reduction upon atomization with the twin-fluid atomizer was 
0.4 ± 0.2 log10(PFU/mL), which was significantly less (p < 0.05). Shear stress during twin-fluid 275 
atomization was therefore not a major cause of titer reduction for phage CP30A. The results 
indicate that the choice of atomization method is important for maximizing biological 
activity. The twin-fluid atomization titer reduction was less than the value of ~0.75 
log10(PFU/mL) reported in the literature (Leung et al., 2016) for anti-Pseudomonas phage 
PEV2 (Podoviridae). Similar shear rates occurred in that study, but greater droplet diameter 280 
reduction via evaporation and hence greater desiccation stress may have occurred. The 
smaller titer reduction observed in this study may also be due to differences in susceptibility 
between phage families. The vibrating mesh nebulizer titer reduction was greater than the 
value of approximately 0.4 log10(PFU/mL) for anti-tuberculosis phage D29 (Siphoviridae) in 
isotonic saline calculated from the literature (Carrigy et al., 2017), indicating that phage 285 
CP30A is potentially more susceptible to titer reduction with this device than phage D29. 
This again may be due to differences in susceptibility between phage families. 
3.3 Spray Drying 
The outlet temperatures matched predictions from the process models to within 2°C for 
both spray dryers. A comparison of spray drying filtered phage CP30A lysate with direct 290 
addition of 7.5 mg/mL leucine and 22.5 mg/mL trehalose using different spray dryers is 
given in Table 1. Use of the B-191 spray dryer resulted in significantly less (p < 0.025) overall 
titer reduction than use of the B-90 spray dryer, thus providing some evidence that attrition 
during cyclone collection with the B-191 was not a major cause of titer reduction, as the B-
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90 spray dryer does not have a cyclone. Non-significant differences (p > 0.5) in titer 295 
reduction between the spray dryers occurred when the effects of atomization (results in 
Section 3.2) were subtracted from the overall titer reductions, indicating that another 
common factor, likely desiccation, was a more substantial cause of titer reduction. Since the 
B-191 resulted in less overall titer reduction, it was used for all further spray drying 
experiments. The titer of the powder for the B-191 was approximately 4×108 PFU/g. This is a 300 
high titer and demonstrates the feasibility of production of phage CP30A dry powder via 
spray drying. Whether this titer is suitable for Campylobacter decontamination and 
biocontrol remains a subject of future research.  
[Insert Table 1] 
The results of titer reduction due to spray drying excluding atomization were not 305 
significantly different (p > 0.2) from the titer reduction for the corresponding air drying case 
from Section 3.1, 1.8 ± 0.3 log10(PFU/mL), providing further evidence that desiccation stress 
was the main cause of titer reduction. This was not unexpected, as literature indicates that 
many phages are susceptible to desiccation stress (Cambell-Renton, 1941). Larger overall 
titer reductions were observed as compared to other phages in the literature using similar 310 
formulation (see Introduction), indicating these anti-Campylobacter phages may be highly 
susceptible to inactivation by desiccation. This provides evidence that phage formulation 
and processing has to be developed on a case-by-case basis. 
The overall titer reduction for filtered and centrifuged phage lysates (CP30A and CP20) 
diluted into leucine and trehalose and spray-dried using the Büchi B-191 with inlet 315 
temperatures of either 70°C or 50°C are given in Table 2. None of the overall titer reduction 
results were significantly different (p > 0.1) indicating that heat stress due to these 
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moderate drying gas inlet temperatures was not a likely cause of titer reduction and that 
the anti-Campylobacter phages tested had similar susceptibility. The overall titer reductions 
due to spray drying the ‘Neat’ filtered lysates at 70°C were 2.5 ± 0.1 log10(PFU/mL) for 320 
CP30A and 2.8 ± 0.2 log10(PFU/mL) for CP20. Excluding atomization, the titer reduction for 
spray drying ‘Neat’ phage CP30A was not significantly different (p > 0.2) than the 
corresponding air drying case, in agreement with the previous results suggesting that 
desiccation was the main cause of titer reduction. Spray drying ‘Neat’ filtered lysates 
resulted in significantly greater (p < 0.01) titer reductions than spray drying with leucine and 325 
trehalose for both phage types at the same inlet temperature of 70°C. This indicated that 
use of leucine and trehalose improved biological stability relative to the case without 
excipients. TEM images of desiccated phage CP20 are given in Figure 6. It was observed that 
many desiccated phages had burst capsids and leaked DNA that would render them inactive. 
TEM (not shown) also indicated that some phages without burst capsids appeared damaged 330 
or had contracted tails that would render them inactive.  
[Insert Figure 6] 
[Insert Table 2] 
The SEM images in Figure 7 demonstrate that with centrifugation and dilution of the filtered 
phage lysate, the spray-dried particle morphology consisted of a semi-spherical shape with 335 
some dimples. This was comparable to the spray-dried leucine and trehalose vehicle, but 
was not as collapsed. On the other hand, the spray-dried ‘Neat’ filtered lysate particles were 
wrinkled and similar to spray-dried filtered lysate particles generated without centrifugation 
and dilution steps. This indicated that the impurities concentrated on the surface and 
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affected the particle morphology and the lowering of impurity concentration by 340 
centrifugation and dilution minimizes this surface concentration effect.  
[Insert Figure 7] 
Using TEM (Figure 8), it was observed that the impurities were mainly bacterial debris that 
had passed through the 0.22 µm filter. This debris may contain a number of bacterial 
components including amino acids, lipids, and sugars, among others.  345 
[Insert Figure 8] 
The surface concentration of the phages, excipients, and impurities is controlled by the 
Péclet number, a dimensionless number used to characterize the ratio of surface recession 
rate due to droplet evaporation and diffusional rate of the solute and suspended matter to 
the interior of the droplet (Vehring, 2008). A high Péclet number (> 1) indicates the solute 350 
and suspended matter will concentrate on the surface, while a low Péclet number (< 1) 
indicates the solute and suspended matter will be relatively evenly distributed (Vehring, 
2008). Furthermore, the surface enrichment is defined as the ratio of surface concentration 
of a component to its mean bulk concentration; surface enrichment increases with 
increasing Péclet number (Boraey & Vehring, 2014). The reason the impurities affected the 355 
surface morphology is probably that at least some of the impurity components are large and 
slowly diffusing, thus having a high Péclet number, surface enrichment, and surface 
concentration, which affected particle formation and shell deformation. The phages are also 
relatively large and therefore have a high Péclet number and surface enrichment. Thus, it is 
possible that the phages would tend to come into contact with the impurities at the surface, 360 
which could be detrimental as the impurities are unlikely to be effective glass stabilizers and 
may physically separate the phages from the stabilizing trehalose. Therefore, the 
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effectiveness of excipients likely depends on the level of purification and the phage 
preparation method.    
Relative to the overall titer reduction results in Table 1, the results in Table 2 indicate that 365 
the use of centrifugation and dilution of the filtered lysate resulted in significantly less (p < 
0.025), ~0.5 log10(PFU/mL) less, overall titer reduction due to spray drying, than adding the 
excipients directly to the filtered phage lysate. This is likely because centrifugation and 
dilution resulted in a mean impurity concentration in the formulation of less than 0.005 
mg/mL, whereas without it the filtered lysate had a mean impurity concentration of ~19 370 
mg/mL. Even with high surface enrichment, the surface concentration of impurities if 
centrifugation and dilution steps are used is relatively small. Considering also the higher 
overall titer reduction upon spray drying ‘Neat’ filtered lysate rather than that with leucine 
and trehalose, it was deduced that the impurities in the filtered phage lysate did not provide 
effective biological stabilization and should be minimized in phage formulation for spray 375 
drying.  
In view of the small batch size of 600 mg, good manufacturability was observed with a high 
spray drying yield (mass collected in the collection bottle relative to the total formulated 
mass of solute and suspended matter) of 72-80%, for centrifuged and diluted filtered phage 
lysates spray-dried with leucine and trehalose. This was much higher than the yield for the 380 
‘Neat’ powders of 5-26%, indicating the leucine and trehalose substantially decreased the 
cohesiveness. The leucine and trehalose addition generated a white powder with improved 
flowability and allowed for easier powder handling and filling into vials with no noticeable 
electrostatic problems.  
3.4 Shipping Stability 385 
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The temperature during shipment of packages LT(1), LT(2), and LT(3) from Canada to 
England was 23 ± 7°C (measured every 4 minutes), with a maximum excursion of 38°C for 
approximately 1.5 hours; the temperature remained above 35°C for approximately 4.5 
hours. The temperature during shipment of LT(3) from England to Canada was 22 ± 2°C, with 
a maximum temperature of 24°C. The temperature during shipment of LT(3) and LT(4) from 390 
Canada to England was 22 ± 4°C, with a maximum excursion of 29°C for approximately 1.5 
hours.  
De-convoluted Raman spectra of the powder indicated that the leucine was partially 
crystalline. The trehalose was fully amorphous, as expected (see Section 2.6), and therefore 
capable of preserving biological activity by glass stabilization. 395 
The overall titer reduction for LT(1) was 1.9 ± 0.1 log10(PFU/mL), which was not significantly 
different (p > 0.2) than the titer reduction of 2.0 ± 0.2 log10(PFU/mL) for the corresponding 
air drying case without shipping. This indicated that the titer reduction was most likely 
caused by desiccation during processing in all cases and not by shipping. This was 
substantiated by shipping multiple times, with additional titer reductions for LT(2), LT(3), 400 
and LT(4) of 0.1 ± 0.2 log10(PFU/mL), 0.0 ± 0.1 log10(PFU/mL), and 0.1 ± 0.1 log10(PFU/mL), 
respectively. There were no significant differences in titer reduction between any of these 
powders (p > 0.05), indicating that shipping the packaged powder three times instead of 
once was not a cause of additional titer reduction and that 3 weeks of room temperature 
storage in the packaging was not a cause of additional titer reduction. To our knowledge, 405 
this is the first shipping stability study that demonstrates that the cold chain is not necessary 
with proper formulation and packaging of phage powder. 
4 Conclusions 
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Biologically-active and thermally-stable dry powder containing anti-Campylobacter phage 
can be produced by spray drying. Maximizing biological activity requires a prudent choice of 410 
atomization method. Use of a twin-fluid atomizer resulted in negligible harm to the phages 
due to shear stress and is recommended over use of a vibrating mesh nebulizer. The 
effectiveness of excipients at preserving biological activity depends on the level of 
purification and the phage preparation method. Centrifuging and diluting the filtered phage 
lysate into leucine and trehalose prior to spray drying improved biological activity retention 415 
relative to use of no excipients or incorporation of excipients directly into the filtered lysate, 
due to minimization of lysate impurity concentrations. The generated low cost powder was 
flowable and non-cohesive, and exhibited a high manufacturing yield. The developed 
packaging method for controlling moisture level and hence maintaining a sufficiently high 
glass transition temperature to prevent trehalose crystallization may be useful in many 420 
global health applications requiring global distribution without cold chain infrastructure. 
This was demonstrated by successful retention of biological activity following 3 weeks of 
room temperature storage and long distance ambient temperature shipping with measured 
temperature excursion. Although use of leucine and trehalose improved biological stability 
relative to use of no excipients, future work is of interest to further decrease biological 425 
activity losses due to desiccation, for example, by incorporation of different excipients. As 
phages have different susceptibilities to desiccation stress, formulation efforts should be 
phage-specific and begin early in the pharmaceutical development process.  
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Figure Captions 
Figure 1. TEM image of phage CP30A prepared using the method described by Carrigy et al. 605 
(2017). 
Figure 2. Schematic of the experiments used to determine the titer reduction due to 
atomization for a vibrating mesh nebulizer (left) and a custom twin-fluid atomizer (right). 
Full resolution colour image available online. 
Figure 3. Process schematics of the spray dryer installations for the modified Büchi B-90 610 
(top) and the Büchi B-191 with upgraded process analytics and controls (bottom). Important 
variables are denoted. 
Figure 4. Dry packaging method. Full resolution colour image available online. 
Figure 5. Timeline and protocol of the shipment study. Measurements were performed 
using different shipments containing powder, composed of filtered and centrifuged phage 615 
CP30A lysate diluted 1:100 in 20 mg/mL leucine and 100 mg/mL trehalose. This powder was 
from the same spray-dried batch aliquoted into different tubes, each shipped in different 
packages. 
Figure 6. TEM images showing DNA leaks from burst capsids of desiccated (air dried) phage 
CP20. A TEM image of phage CP20 without a burst capsid was shown in Figure 1. 620 
Figure 7. SEM images of powder spray-dried using a 70°C inlet temperature. Top-left: spray-
dried ‘Neat’ filtered CP30A lysate; titer reduction 2.5 ± 0.1 log10(PFU/mL). Top-right: spray-
dried filtered CP30A lysate with direct addition of 7.5 mg/mL leucine and 22.5 g/mL 
trehalose; titer reduction 2.3 ± 0.2 log10(PFU/mL) as per Table 1. Bottom-left: spray-dried 
filtered CP30A lysate centrifuged and diluted (CD) 1:100 in 7.5 mg/mL leucine and 22.5 g/mL 625 
trehalose; titer reduction 1.8 ± 0.2 log10(PFU/mL) as per Table 2. Bottom-right: spray-dried 
7.5 mg/mL leucine and 22.5 g/mL trehalose vehicle containing no phages. The microparticles 
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appeared similar for a 50°C inlet temperature and for phage CP20. The same scale bar 
applies to all images. 
Figure 8. TEM showing bacterial debris that passed through the 0.22 µm filter.  630 
